Aligos Therapeutics (ALGS) News Today $8.36 -0.43 (-4.89%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$9.22 +0.87 (+10.35%) As of 07/11/2025 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALGS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 11 at 8:30 AM | globenewswire.comAligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)June 18, 2025 | globenewswire.comAligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 13, 2025 | globenewswire.comAligos Therapeutics to Present at the Jefferies Global Healthcare ConferenceMay 29, 2025 | globenewswire.comAligos Stock Price HistoryMay 26, 2025 | investing.comAligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of LegalMay 20, 2025 | globenewswire.comAligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 16, 2025 | globenewswire.comAligos Therapeutics Presents Positive Data at the EASL Congress 2025May 8, 2025 | globenewswire.comAligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial ResultsMay 6, 2025 | globenewswire.com4ALGS : Aligos Therapeutics's Earnings OutlookMay 6, 2025 | benzinga.comAligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025April 29, 2025 | globenewswire.comAligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025April 23, 2025 | globenewswire.comAligos Therapeutics' (ALGS) "Buy" Rating Reiterated at HC WainwrightApril 1, 2025 | marketbeat.comAligos Therapeutics files to sell 6.25M shares of common stock for holdersMarch 29, 2025 | markets.businessinsider.comA Path to a Healthier Future With Chronic Hepatitis B Virus InfectionMarch 28, 2025 | usatoday.comAligos Therapeutics presents positive data at APASL2025March 27, 2025 | markets.businessinsider.comAligos Therapeutics Presents Positive Data at APASL 2025March 26, 2025 | globenewswire.comTen option delistings on March 24thMarch 24, 2025 | markets.businessinsider.com30,570 Shares in Aligos Therapeutics, Inc. (NASDAQ:ALGS) Purchased by Avantax Advisory Services Inc.March 19, 2025 | marketbeat.comAligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 14, 2025 | globenewswire.comAligos Therapeutics Faces Challenges in Developing Hepatitis B Treatments Amidst Industry CompetitionMarch 12, 2025 | tipranks.comAligos Therapeutics price target lowered to $70 from $75 at H.C. WainwrightMarch 11, 2025 | markets.businessinsider.comAligos Therapeutics reports Q4 EPS ($13.08) vs ($5.50) last yearMarch 10, 2025 | markets.businessinsider.comAligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial ResultsMarch 10, 2025 | globenewswire.comAligos Therapeutics, Inc. (NASDAQ:ALGS) Short Interest Up 23.7% in FebruaryMarch 5, 2025 | marketbeat.comAligos Therapeutics (ALGS) to Release Earnings on TuesdayMarch 4, 2025 | marketbeat.comAligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025March 3, 2025 | globenewswire.comAligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Large Decrease in Short InterestFebruary 17, 2025 | marketbeat.comAligos Therapeutics announces $105M private placement financingFebruary 12, 2025 | markets.businessinsider.comAligos Therapeutics secures $105 million in private placementFebruary 12, 2025 | msn.comAligos Therapeutics Announces $105 Million Private Placement FinancingFebruary 12, 2025 | globenewswire.comHere's Why Aligos Therapeutics (NASDAQ:ALGS) Must Use Its Cash WiselyFebruary 8, 2025 | finance.yahoo.comAligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Large Increase in Short InterestJanuary 30, 2025 | marketbeat.comDrive Wealth Management LLC Acquires New Holdings in Aligos Therapeutics, Inc. (NASDAQ:ALGS)January 27, 2025 | marketbeat.comAligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Significant Growth in Short InterestJanuary 16, 2025 | marketbeat.comAligos Therapeutics, Inc.'s (NASDAQ:ALGS) biggest owners are retail investors who got richer after stock soared 17% last weekDecember 21, 2024 | finance.yahoo.comCharles Schwab Investment Management Inc. Lowers Stake in Aligos Therapeutics, Inc. (NASDAQ:ALGS)December 21, 2024 | marketbeat.comAligos Therapeutics announces inducement grants under Nasdaq listing ruleDecember 14, 2024 | markets.businessinsider.comAligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 13, 2024 | globenewswire.comAligos Therapeutics: Promising Pipeline With Cash And Dilution RisksDecember 11, 2024 | seekingalpha.comBaker BROS. Advisors LP Has $719,000 Position in Aligos Therapeutics, Inc. (NASDAQ:ALGS)December 2, 2024 | marketbeat.comAligos Therapeutics to Present at Investor Conferences in DecemberNovember 26, 2024 | markets.businessinsider.comAligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024November 19, 2024 | globenewswire.comAligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Large Growth in Short InterestNovember 14, 2024 | marketbeat.comAligos Therapeutics trading halted, volatility trading pauseNovember 12, 2024 | markets.businessinsider.comAligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial ResultsNovember 6, 2024 | globenewswire.comAligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Large Drop in Short InterestOctober 27, 2024 | marketbeat.comAligos Therapeutics (NASDAQ:ALGS) Shares Down 5.4% - What's Next?October 25, 2024 | marketbeat.comAligos Therapeutics (NASDAQ:ALGS) Sees Unusually-High Trading Volume - Should You Buy?October 24, 2024 | marketbeat.comAligos Therapeutics’ Promising Clinical Advancements and Buy Rating Driven by Strong Market PotentialOctober 24, 2024 | markets.businessinsider.com Get Aligos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALGS and its competitors with MarketBeat's FREE daily newsletter. Email Address ALGS Media Mentions By Week ALGS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALGS News Sentiment▼0.940.99▲Average Medical News Sentiment ALGS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALGS Articles This Week▼21▲ALGS Articles Average Week Get Aligos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Organigram Global News Today ProKidney News Today Alumis News Today Eledon Pharmaceuticals News Today Cybin News Today Instil Bio News Today Puma Biotechnology News Today Voyager Therapeutics News Today Tiziana Life Sciences News Today I-Mab News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALGS) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aligos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aligos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.